Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
暂无分享,去创建一个
Tongqing Zhou | Ron Diskin | Peter D. Kwong | Michael S. Seaman | Florian Klein | Pamela J. Bjorkman | Johannes F. Scheid | Michel C. Nussenzweig | Marie Pancera | Ivelin S. Georgiev | M. Nussenzweig | P. Bjorkman | I. Georgiev | T. Zhou | P. Kwong | M. Pancera | H. Mouquet | R. Diskin | M. Seaman | Thiago Y. Oliveira | J. Scheid | Hugo Mouquet | F. Klein | C. Gaebler | Reha-Baris Incesu | Brooks Zhongzheng Fu | Priyanthi N. P. Gnanapragasam | Christian Gaebler | Reha-Baris Incesu | Priyanthi N.P. Gnanapragasam | R. Incesu
[1] C. Milstein,et al. Kinetic maturation of an immune response , 1991, Nature.
[2] Richard T. Wyatt,et al. Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables , 2009, Journal of Virology.
[3] J. Weill,et al. Hypermutation generating the sheep immunoglobulin repertoire is an antigen-independent process , 1995, Cell.
[4] K. Rajewsky. Clonal selection and learning in the antibody system , 1996, Nature.
[5] N. Haigwood,et al. Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys , 1999, Nature Medicine.
[6] Holly Janes,et al. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies , 2009, Journal of Virology.
[7] M. Nussenzweig,et al. Autoreactivity in human IgG+ memory B cells. , 2007, Immunity.
[8] Yan Liu,et al. A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield , 2011, Science.
[9] Martin A. Nowak,et al. Antibody neutralization and escape by HIV-1 , 2003, Nature.
[10] P. T. Jones,et al. Replacing the complementarity-determining regions in a human antibody with those from a mouse , 1986, Nature.
[11] R L Stanfield,et al. Crystal structures of an antibody to a peptide and its complex with peptide antigen at 2.8 A. , 1992, Science.
[12] D. Burton,et al. Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo , 2012, Proceedings of the National Academy of Sciences.
[13] Bette Korber,et al. Structure of a V3-Containing HIV-1 gp120 Core , 2005, Science.
[14] F. Pereyra,et al. A method for identification of HIV gp140 binding memory B cells in human blood. , 2009, Journal of immunological methods.
[15] M. Neuberger,et al. Affinity dependence of the B cell response to antigen: a threshold, a ceiling, and the importance of off-rate. , 1998, Immunity.
[16] Q. Sattentau,et al. Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected Individuals , 2010, PloS one.
[17] Richard T. Wyatt,et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals , 2009, Nature.
[18] D. Burton,et al. Very Few Substitutions in a Germ Line Antibody Are Required To Initiate Significant Domain Exchange , 2010, Journal of Virology.
[19] C. Milstein,et al. Codon bias targets mutation , 1995, Nature.
[20] D. Burton,et al. Rapid development of glycan-specific, broad, and potent anti–HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque , 2011, Proceedings of the National Academy of Sciences.
[21] Marie-Paule Lefranc,et al. IMGT, the international ImMunoGeneTics database. , 1997, Nucleic acids research.
[22] Baoshan Zhang,et al. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody , 2012, Nature.
[23] R. Poljak,et al. Three-dimensional structure of immunoglobulins. , 1979, Annual review of biochemistry.
[24] Ron Diskin,et al. HIV therapy by a combination of broadly neutralizing antibodies in humanized mice , 2012, Nature.
[25] P. Emsley,et al. Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.
[26] Tongqing Zhou,et al. Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 , 2009, Science.
[27] Lynn Morris,et al. Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein , 2012, The Journal of experimental medicine.
[28] Tongqing Zhou,et al. Structural definition of a conserved neutralization epitope on HIV-1 gp120 , 2007, Nature.
[29] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.
[30] M. Luftig,et al. Structural basis for HIV-1 neutralization by a gp41 fusion intermediate–directed antibody , 2006, Nature Structural &Molecular Biology.
[31] S. Zolla-Pazner,et al. Structural basis of the cross-reactivity of genetically related human anti-HIV-1 mAbs: implications for design of V3-based immunogens. , 2009, Structure.
[32] Mario Roederer,et al. Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing , 2011, Science.
[33] Michael S. Seaman,et al. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies , 2012, Proceedings of the National Academy of Sciences.
[34] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[35] Peter D. Kwong,et al. Structure and Mechanistic Analysis of the Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 in Complex with Its gp41 Epitope , 2004, Journal of Virology.
[36] A. Trkola,et al. Generation of human monoclonal antibodies against HIV-1 proteins; electrofusion and Epstein-Barr virus transformation for peripheral blood lymphocyte immortalization. , 1994, AIDS research and human retroviruses.
[37] D. Montefiori,et al. Evaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays , 2004, Current protocols in immunology.
[38] S. Zolla-Pazner,et al. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. , 1993, Journal of immunology.
[39] Xiping Wei,et al. Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.
[40] Tongqing Zhou,et al. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.
[41] Maxim N. Artyomov,et al. Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation , 2010, Nature.
[42] Ron Diskin,et al. Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design , 2011, Science.
[43] M. Nussenzweig,et al. Human anti–HIV-neutralizing antibodies frequently target a conserved epitope essential for viral fitness , 2010, The Journal of experimental medicine.
[44] J. Mascola,et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies , 2000, Nature Medicine.
[45] S. Zolla-Pazner,et al. Crystal Structures of Human Immunodeficiency Virus Type 1 (HIV-1) Neutralizing Antibody 2219 in Complex with Three Different V3 Peptides Reveal a New Binding Mode for HIV-1 Cross-Reactivity , 2006, Journal of Virology.
[46] Sergio Roa,et al. The biochemistry of somatic hypermutation. , 2008, Annual review of immunology.
[47] Young Do Kwon,et al. Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility , 2009, Proceedings of the National Academy of Sciences.
[48] Wolfgang Kabsch,et al. Integration, scaling, space-group assignment and post-refinement , 2010, Acta crystallographica. Section D, Biological crystallography.
[49] R. Poljak,et al. Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution , 1986, Science.
[50] M. Nussenzweig,et al. Memory B Cell Antibodies to HIV-1 gp140 Cloned from Individuals Infected with Clade A and B Viruses , 2011, PloS one.
[51] C. H. Bell,et al. Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization. , 2008, Journal of molecular biology.
[52] Ping Zhu,et al. Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition , 2003, Science.
[53] T. Kepler,et al. Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting , 2011, PloS one.
[54] G Himmler,et al. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1 , 1993, Journal of virology.
[55] Pham Phung,et al. Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.
[56] Ron Diskin,et al. Structure of a clade C HIV-1 gp120 bound to CD4 and CD4-induced antibody reveals anti-CD4 polyreactivity , 2010, Nature Structural &Molecular Biology.
[57] Ian A Wilson,et al. Structural basis of enhanced binding of extended and helically constrained peptide epitopes of the broadly neutralizing HIV-1 antibody 4E10. , 2007, Journal of molecular biology.
[58] D. Dimitrov,et al. Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies , 2009, Viruses.
[59] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[60] Pham Phung,et al. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.
[61] Peter D. Kwong,et al. Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4 , 2007, Science.
[62] Robyn L Stanfield,et al. Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D. , 2004, Structure.
[63] M. Nussenzweig,et al. AID targeting in antibody diversity. , 2011, Advances in immunology.
[64] David G. Schatz,et al. Targeting of somatic hypermutation , 2006, Nature Reviews Immunology.
[65] Terri Wrin,et al. Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm , 2009, Journal of Virology.
[66] Young Do Kwon,et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 , 2011, Nature.
[67] Virginia Pascual,et al. Somatic Hypermutation Introduces Insertions and Deletions into Immunoglobulin V Genes , 1998, The Journal of experimental medicine.
[68] Ron Diskin,et al. Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding , 2011, Science.
[69] G. Gonnet,et al. Exhaustive matching of the entire protein sequence database. , 1992, Science.
[70] T. T. Wu,et al. AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITY , 1970, The Journal of experimental medicine.
[71] E. Kabat,et al. Sequences of proteins of immunological interest , 1991 .
[72] Patrice Duroux,et al. IMGT/LIGM-DB, the IMGT® comprehensive database of immunoglobulin and T cell receptor nucleotide sequences , 2005, Nucleic Acids Res..
[73] J. Sodroski,et al. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding , 1993, Journal of virology.
[74] D. Dimitrov,et al. Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens , 2009, Biochemical and Biophysical Research Communications.
[75] A. Trkola,et al. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1 , 1996, Journal of virology.
[76] M. Altfeld,et al. Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1 , 2011, PLoS pathogens.